Telix Pharmaceuticals to host R&D Day for institutional investors and analysts

• Telix Pharmaceuticals will host an R&D Day in New York City on September 22, 2026, scheduled for 8:30 a.m. to 12:30 p.m. EDT.
• The session will outline pipeline and portfolio updates across therapeutics and precision medicine for institutional investors and analysts.
• A Capital Markets Day is set for Melbourne on November 4, 2026, covering strategy, growth outlook, financial targets, and business priorities.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Telix Pharmaceuticals Ltd. published the original content used to generate this news brief on August 05, 2026, and is solely responsible for the information contained therein.